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 Abstract 
 Background/Aims: Oxidative stress is involved in Alzheimer disease pathology, but its impact 
on cognitive function in community-dwelling older adults remains unknown. We estimated 
associations between serum oxidative stress markers and cognitive function in early old age. 
 Methods: Subjects aged 45–69 years recruited in urban centers in Central and Eastern Europe 
had memory, verbal fluency, and processing speed assessed at baseline (2002–2005) and 3 
years later. Derivatives of reactive oxygen metabolites (d-ROMs), biological antioxidant po-
tential (BAP), and total thiol levels (TTLs) were measured at baseline in a subsample. Linear 
regression was used to estimate associations of biomarkers with cognitive test scores cross-
sectionally ( n = 4,304) and prospectively ( n = 2,882).  Results: Increased d-ROM levels were 
inversely associated with global cognition and verbal fluency cross-sectionally and in pro-
spective analysis; observed effects corresponded to 3–4 years’ higher age. TTL was inconsis-
tently associated with memory. BAP was not related to cognitive function.  Conclusion: This 
study found modest evidence for a relationship between serum d-ROMs and cognitive func-
tion in a population sample of older adults.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
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 Introduction 
 The oxidative stress/free radical theory remains one of the leading mechanistic explana-
tions of aging  [1] . Irreversible oxidative damage of cells and organs is seen to progressively accu-
mulate as a consequence of the growing systemic imbalance between the production of reactive 
oxygen species (ROS) and oxygen-derived free radicals and the available antioxidant defenses. 
The resulting oxidative stress contributes to age-related functional decline and increased risk for 
a number of chronic diseases. Harman  [2] first advanced the free radical theory in 1954, and 
recent research has extended it to work on a range of outcomes, including healthy lifespan  [3] .
 One of the key outcomes where oxidative stress is hypothesized to play an important role 
is Alzheimer disease (AD)  [4] . AD is the principal cause of dementia and is characterized by 
progressive decline in memory and other cognitive abilities  [5] . Even in the absence of overt 
dementia, impaired cognitive status is associated with great personal and social costs  [6] . 
Furthermore, as dementia involves changes over a long period, perhaps decades  [7] , there is 
increasing interest in the determinants of individual differences in cognitive performance in 
adulthood  [8] . Identification of reliable oxidative stress markers which could serve as 
biomarkers of aging may not only increase our understanding of age-related cognitive decline 
but also help to identify individuals at a greater risk of future cognitive impairment.
 Patients with AD and mild cognitive impairment have shown elevation of markers of lipid 
peroxidation and decreased total antioxidant capacity of blood, indicating an increase in 
oxidative stress  [9] . However, this relationship has rarely been investigated in the general 
population. An early community study found greater subsequent cognitive decline at high 
levels of systemic oxidative stress as measured by thiobarbituric acid-reactive substances 
 [10] ; however, lipid peroxidation is not seen to be a universal marker of oxidative stress 
status  [11] , and the possibility of cognitive domain-specific differences in vulnerability to 
oxidative stress remains to be investigated. In addition, the disappointing results of clinical 
trials with antioxidants conflict with the studies demonstrating that different biomarkers of 
oxidative stress are elevated in the brain of AD patients and with epidemiologic studies which 
show that dietary antioxidants reduce the risk of AD, suggesting that the role of oxidative 
stress in AD and cognitive decline is yet to be firmly established  [12] .
 The lack of population-based studies may partly reflect the relative difficulty and cost of 
measuring antioxidant potential of stored blood samples. However, the recent availability of 
simpler methods for detecting ROS by using derivatives of reactive oxygen metabolites 
(d-ROMs) and biological antioxidant potential (BAP) has led to their increasing use in large 
population studies  [13–15] .
 Accordingly, the aim of the present study was to investigate the associations of serum 
oxidative stress markers (d-ROM levels, total thiol levels [TTLs], and BAP) with cognitive 
performance in older adults in 3 Central and Eastern European cohorts in cross-sectional and 
prospective analyses.
 Materials and Methods 
 Study Populations and Participants 
 The HAPIEE (Health, Alcohol and Psychosocial Factors in Eastern Europe) study protocol has been 
described previously  [16] . Because of legal restrictions on exporting human biological materials from Russia, 
biomarkers were not measured in the Novosibirsk cohort ( n = 9,360), so only 3 of the 4 cohorts were included 
in the current analysis. Random samples of men and women aged 45–69 years at baseline were recruited in 
Krakow, Poland ( n = 10,728), and in 6 middle-sized Czech towns ( n = 8,857) in 2002–2005 and in Kaunas, 
Lithuania ( n = 7,161), in 2006–2008. The response rates were 61% in Krakow, 65% in Kaunas, and 55% in 
Czech towns. Baseline data were collected by questionnaire and a short clinical examination, which included 
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drawing a fasting venous blood sample. Czech and Krakow participants were visited by a nurse in their homes 
to complete the questionnaire and invited to a clinic for the examination. In Kaunas, both the questionnaire and 
examination were completed at a clinic. The second wave of data was collected by questionnaire in 2006–2008 
in Czech towns and Krakow (this was the baseline survey in Kaunas), with an overall response rate of 61%. 
 At Czech and Krakow baseline, cognitive assessment ( n = 7,975) was conducted in participants aged 60 
years or over and a random sample of approximately 20% of participants younger than 60 years. In 2006–
2008, cognitive assessment was completed by all Kaunas participants ( n = 7,059) and all participants at 
follow-up in Czech towns and Krakow irrespective of their age ( n = 11,832); for 57.5% ( n = 6,801) of Czech 
and Polish participants, this was the first cognitive assessment. Cognitive assessment was conducted at a 
clinic, except for Krakow, where it took place in participants’ homes. 
 Because of limited funding, biomarkers were analyzed in a nested case-control study. From 26,746 
participants eligible for the nested case-control study, 3,462 participants were excluded a priori because they 
were missing a blood sample, another 1,867 had not consented to follow-up assessments, and 208 had an 
unconfirmed cardiovascular event. Cases ( n = 1,882) were participants who died from any cause or experi-
enced a nonfatal cardiovascular event (myocardial infarction [MI] or stroke) between baseline and December 
31, 2010 (December 31, 2009, in Krakow). Each case was matched to at least 2 controls drawn randomly 
from the study population by age (in 5-year bands), sex, and study center ( n = 4,476).
 Cognitive Assessment 
 Cognitive function was assessed by 4 neuropsychological tests, as described previously  [17] : (1) imme-
diate word recall (10 nouns over 3 consecutive 1-min trials; possible range 0–30); (2) delayed recall (10 
nouns following an interval; possible range 0–10), both used as tests of verbal memory and learning; (3) 
verbal fluency (animal naming) used as a measure of language and executive function, and (4) processing 
speed measured by timed letter cancellation test (possible range 0–65).
 Assessment of Oxidative Stress Biomarkers in Serum 
 The selection of biomarkers was based on their suitability as indicators of antioxidant status in large-
scale studies  [14] . Serum samples were analyzed in 2012–2013 after being stored in freezers at –80  °  C for 
3–10 years; all biomarkers analyzed were shown to have adequate long-term stability under these conditions 
 [18, 19] . Biomarkers were determined using an autoanalyzer (LX20-Pro, Beckman-Coulter, Woerden, The 
Netherlands). BAP and d-ROM kits were obtained from Diacron Labs (Diacron International s.r.l., 2016, 
Grosseto, Italy). TTL was obtained from Rel Assay Diagnostics (2016, Gaziantep, Turkey).
 Concentration of d-ROMs was used as an index for the production of ROS, with high values indicating 
higher oxidative stress. The d-ROMs assay measures the hydroperoxide concentration based on the principle 
that the amount of organic hydroperoxides present in serum is related to the levels of free radicals from which 
they are formed  [20–22] . The results of the assay are expressed in Carratelli units (U.CARR), where one U.CARR 
corresponds to 0.8 mg/L of hydrogen peroxide (H 2 O 2 ). BAP reflects the total antioxidant capacity of serum. The 
BAP assay, expressed in meq/L, is a simple photometric test which measures the concentration of total anti-
oxidants by their capacity to reduce iron from the ferric to the ferrous form. TTL, expressed in μmol/L, was 
used as a marker of protein oxidation  [23] . The number of free thiol groups as cysteine residues in proteins 
measures favorable redox status, and a low number of thiol groups is indicative of increased oxidative stress.
 Biomarkers were assayed at different times in different centers (Czech towns in May 2012, Krakow in 
July 2013, and Kaunas in May 2013). To correct for potential shifts in the assays, data from control samples 
were used for calibration. Agreement of d-ROMs measurements between centers was high, and no correction 
was applied. Observed shifts in BAP and TTL assay results were corrected by multiplying them by a relevant 
factor (0.83 and 0.86 for BAP, and 1.26 and 1.46 for TTL in Czech towns and Kaunas, respectively), with assay 
results for Krakow used as the standard. 
 Covariate Assessment 
 We included the following potential covariates in the statistical analysis: age at cognitive assessment, sex, 
study center, case-control status, education (primary or less, secondary, and tertiary), current socioeconomic 
status using employment status (employed, self-employed, retired, retired but still working, unemployed, and 
other), smoking status (never, current, and former), average alcohol intake in the past year expressed in grams 
per day (0, <5, 5–20, and >20 g in women and 0, <10, 10–50, and >50 g in men), and depressive symptoms 
measured by CES-D 20-item scale  [24] (yes vs. no using a score of 16 as the threshold). We also included self-
reported history of major chronic conditions: MI, stroke, hypertension, and diabetes (all yes vs. no).
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 Statistical Analysis 
 To allow comparison between tests, cognitive test results were standardized to z-scores (mean = 0; 
standard deviation [SD] = 1) using the full study sample means  [17] . In addition, a global cognitive score was 
derived by averaging the standardized scores on each of the 4 tests. For all cognitive tests as well as the global 
cognitive score, higher scores indicate better cognitive performance. Levels of d-ROMs and BAP were catego-
rized according to the manufacturer’s instructions. Levels of d-ROMs were categorized into not increased 
( ≤ 340 U.CARR), moderate (341–400 U.CARR), and high oxidative stress (>400 U.CARR). BAP status was 
categorized as deficiency (<2,000 meq/L), borderline deficiency (2000–2,200 meq/L), and normal values 
(>2,200 meq/L). There are currently no established clinical cutoffs for TTL, leading us to quartile them in the 
analysis with the bottom quartile (25%) taken to indicate higher oxidative stress. Cross-sectional associa-
tions of established risk factors for cognitive function with oxidative stress markers were assessed using 
linear regression, with adjustment for age, sex, center, and case-control status. 
 Two sets of analyses were conducted to estimate cross-sectional and prospective associations of 
oxidative stress markers with cognitive performance. All variables used in cross-sectional analysis were 
measured at baseline. In prospective analyses, we used biomarkers and covariates from baseline and 
cognitive function measures from follow-up. As data at follow-up were not collected in Kaunas, only 2 cohorts 
(Czech towns and Krakow) were included in the prospective analysis, where cognitive performance was 
assessed on average 3.7 ± 0.4 years (minimum = 1.8 years; maximum = 5.5 years) later. 
 In both cross-sectional and prospective analyses, linear regression was used to model the association 
of biomarkers (in categories) and cognitive z-scores. To test for linear trend across successive biomarker 
categories, we used biomarkers as ordinal variables in linear regression. We repeated the analysis with 
biomarkers modelled as continuous variables and tested for nonlinearity by including quadratic terms for 
biomarkers in the regression equations.
 As data come from a nested case-control design originally set up to study cardiovascular disease and 
mortality, all regression models were adjusted for case-control status, history of MI or stroke, and matching 
criteria (sex, age group, and study center). The models were then additionally adjusted for education, socio-
economic status, health behaviors, and depression. Finally, we also adjusted the models for history of diabetes 
and hypertension. All covariates were modelled as categorical variables (categories shown in  Table 1 ).
 Prospective models (cognition from follow-up) were additionally adjusted for cognitive testing occasion 
(first test vs. re-test) to control for possible learning effects from repeated test taking. We also controlled for 
follow-up time in prospective models and tested for interactions between biomarkers and the main demo-
graphic variables (sex, age, and study center). In order to facilitate interpretation of the regression coeffi-
cients associated with biomarkers, we compared them with the effect of age on cognition by dividing the 
regression coefficients by the effect of 1-year increase in age on cognition.
 From 6,358 participants included in the nested case-control study, those with incomplete oxidative 
stress ( n = 49) or cognitive data (baseline  n = 1,973; follow-up  n = 3,384) were excluded from the analysis 
(see online suppl. Table S1; for all online suppl. material, see www.karger.com/doi/10.1159/000450702). 
The proportion of missing data of baseline covariates was generally low and ranged from 0.3 to 2.5% per 
covariate. Missing data on covariates at baseline were replaced using multiple imputation by chained equa-
tions  [25] and using all available data for all variables in the analysis to generate 10 imputed datasets. After 
excluding observations with missing data on oxidative stress and cognition, there were 4,304 participants 
available for cross-sectional and 2,882 participants for prospective analysis.
 We conducted a number of sensitivity analyses. First, we restricted the analysis to controls in order to 
ensure that the results were not driven by cases, including persons who had died or had cardiovascular 
disease. Second, we excluded participants who died within 2 years of the baseline survey, suffered a nonfatal 
MI or stroke during follow-up, or had existing hypertension or diabetes at baseline. Finally, we conducted an 
additional complete case analysis in the subset of participants with repeated cognitive measures ( n = 1,540), 
adjusting for baseline cognitive function and also including an interaction term between age and baseline 
cognitive status. All analyses were conducted in Stata 14 (Stata Statistical Software, StataCorp LP, release 14, 
2015, College Station, TX, USA).
 Statement of Ethics 
 The study was approved by the ethics committees at University College London and University College 
Hospital and the local ethics committees in each participating center. Written informed consent was obtained 
from all participants.
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 Table 1.  Descriptive characteristics of the study sample by case-control status in participants with complete observations
Cross-sectional  Prospective
cases
(n = 1,177)
controls
(n = 2,901)
p c ases
(n = 467)
controls
(n = 2,250)
p
Immediate recall 19.7 (4.3) 20.8 (4.0) <0.001 20.9 (4.3) 21.6 (4.0) 0.001
Delayed recall 6.8 (2.0) 7.2 (1.9) <0.001 7.0 (2.0) 7.2 (1.9) 0.020
Verbal fluency 19.9 (6.4) 21.2 (6.4) <0.001 21.8 (6.7) 22.7 (6.4) 0.012
Letter cancellation 15.4 (5.5) 16.7 (5.0) <0.001 16.6 (4.9) 17.5 (4.7) <0.001
d-ROMs, U.CARR 386.6 (86.1) 365.8 (73.9) <0.001 381.5 (85.4) 368.0 (83.1) 0.002
d-ROM categories <0.001 0.001
<340 U.CARR 28.5 35.9 31.7 35.7
341 – 400 U.CARR 32.9 35.6 28.9 34.0
>400 U.CARR 38.7 28.5 39.4 30.3
BAP, meq/L 2,144.2 (194.3) 2,129.1 (194.8) 0.024 2,188.5 (195.2) 2,196.7 (201.5) 0.410
BAP categories 0.089 0.856
>2,200 meq/L 33.7 31.1 46.0 45.6
2,000 – 2,200 meq/L 44.1 43.8 41.8 41.2
<2,000 meq/L 22.2 25.1 12.2 13.2
TTL, μmol/L 489.5 (90.5) 493.4 (83.7) 0.199 516.8 (86.0) 516.5 (81.5) 0.947
TTL categories 0.869 0.852
4th Q 22.4 23.0 24.0 24.1
3rd Q 24.6 24.8 26.3 25.0
2nd Q 25.1 25.6 24.2 26.0
1st Q 27.9 26.6 25.5 24.9
Age group 0.724 0.242
<50 years 3.0 3.4 1.1 1.9
50 to <55 years 6.1 5.1 10.9 10.1
55 to <60 years 12.6 13.0 15.1 14.1
60 to <65 years 33.5 33.0 23.6 19.6
65 to <70 years 36.8 38.2 28.3 32.2
>70 years 8.0 7.4 20.9 22.0
Center 0.493 0.033
Czech towns 30.4 32.1 55.7 50.3
Krakow 27.3 26.8 44.3 49.7
Kaunas 42.3 41.1 n.a. n.a.
Male 65.9 66.6 0.676 66.8 67.7 0.712
Education <0.001 0.002
Primary or less 15.7 10.5 10.1 8.7
Secondary 57.3 54.0 71.1 64.6
College or university 26.9 35.4 18.8 26.7
SES <0.001 0.031
Employed 12.1 15.6 22.3 22.6
Self-employed 1.5 2.3 3.2 5.3
Retired, still working 11.2 17.3 7.9 11.3
Fully retired 70.2 61.9 62 .5 57.5
Unemployed 2.0 1.0 3.2 2.0
Other 2.9 1.8 0.9 1.3
Smoking status <0.001 <0.001
Never smoker 37.3 50.2 32.8 42.1
Former smoker 31.4 30.9 31.5 34.8
Current smoker 31.4 18.9 35.8 23.1
MI 16.1 9.1 <0.001 10.1 8.1 0.173
Stroke 5.4 3.9 0.042 2.8 2.9 0.861
Hypertension 63.6 59.1 0.008 62.1 52.8 <0.001
Diabetes 20.0 11.7 <0.001 20.1 12.8 <0.001
Alcohol intake, g/day <0.001 0.145
None 21.6 15.5 21.8 19.6
Low 58.0 60.7 57.4 56.1
Medium 16.8 21.1 16.3 20.6
High 3.6 2.6 4.5 3.7
Depressive symptoms 29.6 21.7 <0.001 29.1 21.4 <0.001
 Means and standard deviations in parentheses are presented for continuous variables and proportions for categorical variables.
p values from two-tailed t tests comparing means or χ2 tests of independence between cases and controls. BAP, biological antioxidant 
potential; d-ROMs, derivatives of reactive oxygen metabolites; MI, myocardial infarction; n.a., not applicable; Q, quartile; U.CARR, 
Carratelli units; SES, socioeconomic status; TTL, total thiol level.
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 Results 
 Descriptive characteristics of cases and controls are shown in  Table 1 . Around two thirds 
of participants were male, due to data for the current analyses being drawn from a case-control 
design where men were more likely to be selected due to higher mortality and cardiovascular 
disease rates. Average baseline age of participants was 63.9 years, and age was inversely asso-
ciated with cognitive performance; in cross-sectional analysis, 1-year increase in age was asso-
ciated with –0.03 SD (95% confidence interval [CI] –0.04, –0.03) lower scores on verbal fluency, 
–0.04 SD (95% CI –0.05, –0.04) lower scores on immediate recall, and –0.04 SD (95% CI –0.04, 
–0.03) lower scores on delayed recall, processing speed, and global cognition.
 Table 2. Cross-sectional and prospective associations of d-ROM status, BAP status, and TTL with cognitive performance z-scores
Immediate recall
z-score, β (95% CI)
Delayed recall
z-score, β (95% CI)
Verbal fluency
z-score, β (95% CI)
Letter cancellation
z-score, β (95% CI)
Global cognition, 
β (95% CI)
Cross-sectional (n = 4,304)
d-ROMs
≤340 U.CARR 0.00 0.00 0.00 0.00 0.00
341 – 400 U.CARR –0.01 (–0.08, 0.05) –0.02 (–0.09, 0.05) –0.08 (–0.15, –0.01)* –0.06 (–0.14, 0.01) –0.04 (–0.09, 0.00)
≥401 U.CARR –0.07 (–0.14, 0.00) –0.05 (–0.12, 0.03) –0.09 (–0.17, –0.02)* –0.04 (–0.13, 0.04) –0.06 (–0.12, –0.01)*
p for trend 0.055 0.184 0.012 0.267 0.016
BAP
>2,200 meq/L 0.00 0.00 0.00 0.00 0.00
2,000 – 2,200 meq/L 0.02 (–0.04, 0.09) 0.03 (–0.04, 0.10) 0.03 (–0.04, 0.10) 0.00 (–0.07, 0.08) 0.02 (–0.03, 0.07)
<2,000 meq/L –0.00 (–0.08, 0.08) –0.00 (–0.08, 0.08) 0.07 (–0.01, 0.16) 0.00 (–0.09, 0.10) 0.02 (–0.04, 0.08)
p for trend 0.967 0.987 0.088 0.902 0.506
TTL
4th Q 0.00 0.00 0.00 0.00 0.00
3rd Q –0.02 (–0.10, 0.05) –0.01 (–0.09, 0.07) –0.03 (–0.11, 0.05) 0.06 (–0.03, 0.14) 0.00 (–0.06, 0.06)
2nd Q –0.06 (–0.14, 0.01) –0.04 (–0.12, 0.04) –0.06 (–0.14, 0.02) 0.06 (–0.02, 0.15) –0.02 (–0.08, 0.03)
1st Q –0.08 (–0.15, –0.00)* –0.06 (–0.14, 0.02) –0.02 (–0.09, 0.06) 0.04 (–0.04, 0.13) –0.03 (–0.09, 0.03)
p for trend 0.023 0.081 0.619 0.364 0.233
Prospective (n = 2,882)
d–ROMs
≤340 U.CARR 0.00 0.00 0.00 0.00 0.00
341 – 400 U.CARR –0.01 (–0.09, 0.07) –0.01 (–0.10, 0.07) –0.02 (–0.10, 0.07) 0.02 (–0.06, 0.10) –0.01 (–0.07, 0.05)
≥401 U.CARR –0.12 (–0.21, –0.03)* –0.1 (–0.21, –0.02)*  –0.12 (–0.22, –0.03)** –0.05 (–0.14, 0.05) –0.10 (–0.17, –0.03)**
p for trend 0.012 0.018 0.011 0.360 0.004
BAP
>2,200 meq/L 0.00 0.00 0.00 0.00 0.00
2,000 – 2,200 meq/L 0.01 (–0.06, 0.09) 0.03 (–0.04, 0.11) –0.00 (–0.08, 0.08) –0.00 (–0.08, 0.07) 0.01 (–0.04, 0.07)
<2,000 meq/L 0.08 (–0.03, 0.18) 0.02 (–0.09, 0.13) –0.00 (–0.11, 0.11) –0.02 (0.13, 0.08) 0.02 (–0.06, 0.10)
p for trend 0.188 0.550 0.973 0.730 0.602
TTL
4th Q 0.00 0.00 0.00 0.00 0.00
3rd Q –0.02 (–0.12, 0.07) –0.05 (0.14, 0.05) 0.01 (–0.09, 0.11) –0.04 (–0.13, 0.06) –0.02 (–0.09, 0.04)
2nd Q 0.10 (0.00, 0.19) 0.01 (–0.09, 0.11) 0.02 (–0.08, 0.12) –0.04 (–0.13, 0.06) 0.02 (–0.05, 0.09)
1st Q 0.10 (0.00, 0.20) 0.04 (–0.06, 0.14) 0.02 (–0.08, 0.12) –0.03 (0.13, 0.07) 0.03 (–0.04, 0.10)
p for trend 0.009 0.305 0.761 0.456 0.278
Models are adjusted for age group, sex, study center, education, socioeconomic status, smoking, alcohol, depression, cardiovascular disease history and case-
control status. Prospective models are additionally adjusted for cognitive test versus retest status. p for trend calculated by using biomarker categories as an ordinal 
variable in linear regression. BAP, biological antioxidant potential; CI, confidence interval; d-ROMs, derivatives of reactive oxygen metabolites; Q, quartile; TTL, total 
thiol level; U.CARR, Carratelli units. * p ≤ 0.05; ** p ≤ 0.01.
 Fig. 1. Cross-sectional associations of oxidative stress markers with cognitive scores. Data shown are unstan-
dardized regression coefficients (diamonds) with 95% CIs (solid lines). Model 1 (1st solid line) is adjusted for 
age group, sex, center, case-control status, and cognitive test versus retest status. Model 2 (2nd solid line) is 
additionally adjusted for education, socioeconomic status, smoking, alcohol, depression, history of cardiovas-
cular disease, and stroke. Model 3 (3rd solid line) is additionally adjusted for history of diabetes and hyperten-
sion. Biomarker units: d-ROMs, U.CARR; BAP, meq/L; and TTL, μmol/L. BAP, biological antioxidant potential; 
d-ROMs, derivatives of reactive oxygen metabolites; Q, quartile; TTL, total thiol level; U.CARR, Carratelli units. 
(For figure see next page.)
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 In cross-sectional analyses, d-ROM levels were significantly inversely associated with 
verbal fluency and the global cognitive score ( Table 2 ). The differences in test scores between 
the highest and lowest categories of d-ROMs correspond to an age effect of roughly 3 years 
for verbal fluency and 1.5 years for global cognition. BAP was not related to performance on 
any of the cognitive tests. Compared to those in the top quartile, participants in the bottom 
quartile of TTL had significantly lower scores on immediate and delayed recall tests.
 In prospective analysis ( Table 2 ), high baseline d-ROM levels continued to be inversely 
associated with verbal fluency and the global cognition score at follow-up. High baseline 
d-ROM levels were also inversely associated with immediate and delayed recall at follow-up. 
Comparing with the effect of age, the differences between the highest and lowest categories 
of d-ROMs were equivalent to roughly 4 years for verbal fluency and 2.5 years for global 
cognition. There were no associations between baseline BAP deficiency and any of the 
cognitive domains or global scores at follow-up. In contrast, the prospective association of 
TTL with immediate recall was statistically significant but in the opposite direction to that in 
cross-sectional analyses. After additional adjustment for history of diabetes and hyper-
tension, the associations remained relatively unchanged ( Fig. 1 ,  2 ; online suppl. Fig. S1 for 
global cognition). 
 Results from linear regression using biomarkers as continuous variables were not statis-
tically significant, with the exception of prospective models for d-ROMs and verbal fluency
( p = 0.017) and TTL and immediate recall ( p = 0.018). The models were not significantly 
improved by adding quadratic terms for biomarkers to account for possible nonlinearity. We 
found no significant interactions between biomarkers and study center.
 Sensitivity analyses suggested that results for the observed significant associations of 
d-ROMs and TTL with cognitive performance measures were mostly robust (see online suppl. 
Tables S2–S5). However, the prospective associations of increased d-ROM levels with verbal 
fluency and global cognition were attenuated and no longer significant in an analysis restricted 
to controls (see online suppl. Table S2). In a complete case analysis in the subset of partici-
pants with repeated cognitive measures, adjusting for baseline cognition did not appreciably 
change the pattern of results. The inclusion of an interaction term between baseline cognition 
and age also made no difference in the results. Overall, the associations of d-ROMs with verbal 
fluency and global cognition and of TTL with word recall were weaker in complete case 
analyses compared to analyses using multiply imputed data, possibly reflecting the smaller 
numbers of observations.
 Discussion 
 To the best of our knowledge, this study is the first investigation of serum oxidative stress 
markers in relation to domain-specific cognitive performance in a large general population 
sample of older adults. We found modest associations between oxidative stress markers, 
 Fig. 2. Prospective associations of oxidative stress markers with cognitive scores. Data shown are unstan-
dardized regression coefficients (diamonds) with 95% CIs (solid lines). Model 1 (1st solid line) is adjusted 
for age group, sex, center, case-control status, and cognitive test versus retest status. Model 2 (2nd solid line) 
is additionally adjusted for education, socioeconomic status, smoking, alcohol, depression, history of cardio-
vascular disease, and stroke. Model 3 (3rd solid line) is additionally adjusted for history of diabetes and hy-
pertension. Biomarker units: d-ROMs, U.CARR; BAP, meq/L; and TTL, μmol/L. BAP, biological antioxidant 
potential; d-ROMs, derivatives of reactive oxygen metabolites; Q, quartile; TTL, total thiol level; U.CARR, Car-
ratelli units. 
(For figure see next page.)
D
ow
nl
oa
de
d 
by
: 
UC
L 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
12
8.
41
.3
5.
98
 - 
12
/8
/2
01
6 
5:
35
:0
5 
PM
305Dement Geriatr Cogn Disord 2016;42:297–309
 DOI: 10.1159/000450702 
 Horvat et al.: Blood-Based Oxidative Stress Markers and Cognitive Performance in 
Early Old Age: The HAPIEE Study 
www.karger.com/dem
© 2016 S. Karger AG, Basel
Immediate recall
Prospective
Delayed recall
Verbal fluency Processing speed
d-ROMs
BAP
TTL
?340
????
???????
>2,200
<2,000
4th Q
3rd Q
2nd Q
?????
???????????
d-ROMs
BAP
TTL
?340
????
???????
>2,200
<2,000
4th Q
3rd Q
2nd Q
?????
???????????
??
??
??
??? ??
??
??
??? 0 ???
? ??? ???
? ??? ??
??
??
??? ??
??
??
??? 0 ???
? ??? ???
? ???
??
??
??
??? ??
??
??
??? 0 ???
? ??? ???
? ??? ??
??
??
??? ??
??
??
??? 0 ???
? ??? ???
? ???
??????? Model 2 Model 3
Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e
 2 
D
ow
nl
oa
de
d 
by
: 
UC
L 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
12
8.
41
.3
5.
98
 - 
12
/8
/2
01
6 
5:
35
:0
5 
PM
306Dement Geriatr Cogn Disord 2016;42:297–309
 DOI: 10.1159/000450702 
 Horvat et al.: Blood-Based Oxidative Stress Markers and Cognitive Performance in 
Early Old Age: The HAPIEE Study 
www.karger.com/dem
© 2016 S. Karger AG, Basel
d-ROMs in particular, and cognitive function in early old age. Increased levels of d-ROMs were 
associated with poorer verbal fluency and global cognition both at baseline and at 3-year 
follow-up. TTL was associated with immediate recall, but the pattern of cross-sectional results 
contradicted prospective associations. We observed no association between BAP status and 
cognitive performance.
 Strengths of this study include the objective assessment of serum antioxidant status 
using a combination of biomarkers, assessment of cognitive function by repeated adminis-
tration of neuropsychological tests, large well-characterized samples from 3 Central and 
Eastern European populations, and an extensive assessment of major risk factors for cognitive 
function allowing for control of confounding.
 Several limitations of this study should be mentioned. First, the response rate to the 
baseline survey was relatively low, although similar to most contemporary population-based 
studies  [26] . Responders were more likely to be healthier and socially advantaged than 
nonresponders  [16] ; therefore, slightly healthier and socially advantaged individuals were 
probably overrepresented in our sample. However, we would not expect response rates to 
bias the estimates of the associations between biomarkers and cognition. The second limi-
tation relates to missing data. The prospective sample was restricted to participants with 
cognitive function at follow-up, and attrition appeared to be higher in participants with lower 
baseline cognitive scores. Thus, loss to follow-up could have affected our prospective results. 
As a consequence, potential confounding and bias cannot be definitively ruled out, and causal 
inferences can only be made with caution. Third, because the analytical sample was selected 
in a nested case-control design, the overrepresentation of cases with an increased likelihood 
of dying or dropping out before follow-up is a concern. We included the variables which were 
used to select participants into the case-control study as covariates in the analysis, and this 
approach should produce unbiased estimates. The results of sensitivity analysis restricted to 
controls were also broadly similar to the results of the main analysis, although the prospective 
results for d-ROMs and cognitive function were somewhat weaker than in the main analyses 
(see online suppl. Table S2). Fourth, biomarker measurements were not repeated at follow-
up. However, we have demonstrated that associations of d-ROM levels with performance in 
specific cognitive domains remained statistically significant 3 years after baseline. In addition, 
we used only 2 repeated measurements of cognitive performance collected over a relatively 
short interval, which precluded us from studying decline in cognitive performance over time. 
Finally, our measure of global cognition, although less likely to be affected by measurement 
error than individual tests, has limited coverage as it reflects the tests used to derive it.
 We are not aware of other studies to date which have assessed the association of oxidative 
stress markers with cognitive performance in the general population. An early community 
study in 1,166 participants aged 60–70 years from Nantes (France) found an increased risk 
of decline in MMSE scores over a 4-year period in persons with high baseline levels of thio-
barbituric acid-reactive substances, an indicator of free radical-induced lipid peroxidation 
 [10] . A dose-response effect was also reported between the biomarker levels and odds of 
cognitive decline. In our study, high d-ROM levels were also associated with worse global 
cognition at follow-up and showed a dose-response effect. However, our global cognitive 
score had restricted domain coverage, and we used a different biomarker in a younger sample. 
Therefore, direct comparisons require caution.
 In our study, increased d-ROM levels were inversely associated with verbal fluency and 
global cognition, both cross-sectionally and at 3-year follow-up, and there was evidence for a 
linear trend. High d-ROM levels were also prospectively associated with worse immediate 
and delayed recall. Poorer performance on verbal fluency in participants with increased 
d-ROM levels corresponded to an age effect of roughly 3 years in cross-sectional and 4 years 
in prospective analyses. Age effects for global cognition were roughly 4 years, taking together 
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both cross-sectional and prospective analyses. These effects are not negligible and, given the 
imprecision in measurement of cognition and the probable biological variations in biomarker 
concentrations, it is likely that the associations were underestimated.
 One possible mechanism through which oxidative stress markers, such as d-ROMs, could 
affect cognitive function is vascular risk factors. The role of oxygen free radicals and other 
ROS is considered important in the development of atherosclerosis, stroke, and other cardio-
vascular diseases  [27, 28] ; these conditions are likely to act as risk factors for cognitive decline 
or dementia  [29, 30] . In addition, there is growing evidence that oxidative stress is involved 
in the pathogenesis of both AD and vascular dementia  [31, 32] . Recently, there has also been 
growing recognition that insulin production and signaling are severely impaired in the AD 
brain, resulting in impaired glucose metabolism and mitochondrial function and, in turn, 
increased production of ROS  [33] . However, in this study, adjusting for or excluding partici-
pants with underlying cardiovascular conditions or diabetes did not appear to explain the 
observed associations between d-ROMs and cognitive performance measures.
 Levels of d-ROMs were not associated with processing speed or with memory in cross-
sectional models, although the direction of the association was the same for all cognitive tests 
and differences in the strength of the observed associations may also reflect differences in 
measurement precision  [34] . It is possible that verbal fluency, a measure of executive function, 
is especially sensitive to age-associated changes and disease processes. Future studies should 
use more specific tests of executive function to evaluate the association with blood-based 
oxidative stress markers.
 TTL was associated with immediate recall, but the pattern of cross-sectional and 
prospective associations was in opposite directions. One possible explanation is model 
misspecification; this could include an omitted variable, selection bias, regression to the 
mean, and specification or measurement error. However, having performed various checks 
 [35] , the results did not change substantially. Thiols are a major constituent of the body’s total 
antioxidants, play an important role in the defense against ROS, and their concentrations have 
been shown to be decreased in numerous diseases including cardiovascular disease and 
diabetes  [23] . We are not sure what can explain our inconsistent results.
 In the present study, BAP showed no relation with cognitive performance. In a recent 
cross-sectional study of 2,518 German older persons, BAP also showed inconsistent associa-
tions with frailty  [36] , a marker for future cognitive impairment, which is associated with 
executive function  [37] .
 In this study, d-ROMs emerged as a more promising marker for cognitive aging than BAP 
or, less consistently, TTL. Previously, d-ROMs and TTL were shown to be associated with all-
cause and cardiovascular mortality in a joint analysis of the current cohorts and a German 
cohort  [13] . Blood-based biomarkers could provide cost- and time-effective means of identi-
fying groups at risk of cognitive decline. For example, results from a recent effort to construct 
and validate a risk index for cognitive decline based on blood-based markers were moder-
ately positive. The index, including 8 markers which had previously been shown to be asso-
ciated with cognitive aging, was modestly predictive of 11-year decline on the MMSE after 
controlling for age and baseline cognition  [38] . Findings of our study, if successfully repli-
cated, could be useful to extend such biomarker scores.
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